Compounds > isomethyleugenol
Page last updated: 2024-08-18

isomethyleugenol and Spinal Cord Neoplasms

isomethyleugenol has been researched along with Spinal Cord Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hatanaka, KC; Hida, K; Ishi, Y; Ishida, Y; Oda, Y; Seki, T; Takamiya, S; Tanaka, S; Yamaguchi, S; Yamazaki, K1

Other Studies

1 other study(ies) available for isomethyleugenol and Spinal Cord Neoplasms

ArticleYear
Prognostic role of H3K27M mutation, histone H3K27 methylation status, and EZH2 expression in diffuse spinal cord gliomas.
    Brain tumor pathology, 2020, Volume: 37, Issue:3

    Topics: Enhancer of Zeste Homolog 2 Protein; Gene Expression; Glioma; Histones; Humans; Methylation; Mutation, Missense; Prognosis; Retrospective Studies; Spinal Cord Neoplasms

2020